Clinical validation of an HPV whole-genome sequencing assay for MRD detection in patients with HPV+ head and neck cancer treated with surgery

Science Translational Medicine · Published 2026-06-10 · DOI 10.1126/scitranslmed.aec1724

Authors (24)

Shun Hirayama, Yana Al-Inaya, Michael E. Bryan, Dipon Das, Ling Aye, Saskia Naegele, Julia Mendel, William C. Faquin, Peter M. Sadow, Matthew G. Crowson, Derrick Lin, Mark Varvares, Allen L. Feng, Daniel Deschler, Jonathan Paly, Ross Merkin, Thomas J. Roberts, Michael Lawrence, A. John Iafrate, Lori J. Wirth, Adam S. Fisch, Zoe Guan, Jeremy Richmon, Daniel L. Faden

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Hirayama, S., Al-Inaya, Y., Bryan, M., et al. (2026). Clinical validation of an HPV whole-genome sequencing assay for MRD detection in patients with HPV+ head and neck cancer treated with surgery. Science Translational Medicine. https://doi.org/10.1126/scitranslmed.aec1724

Related articles